Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges

by Bianca C. Bernardo, Bianca C. Bernardo, Bianca C. Bernardo, Paul Gregorevic, Paul Gregorevic, Rebecca H. Ritchie, Rebecca H. Ritchie, Rebecca H. Ritchie, Julie R. McMullen, Julie R. McMullen, Julie R. McMullen, Julie R. McMullen, Julie R. McMullen
Published 2018-09-01

Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrill...

by Bianca C Bernardo, Geeta Sapra, Natalie L Patterson, Nelly Cemerlang, Helen Kiriazis, Tomomi Ueyama, Mark A Febbraio, Julie R McMullen
Published 2015-01-01

Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart

by Duncan Horlock, David M. Kaye, Catherine E. Winbanks, Xiao-Ming Gao, Helen Kiriazis, Daniel G. Donner, Paul Gregorevic, Julie R. McMullen, Bianca C. Bernardo
Published 2021-03-01

Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets

by Yow Keat Tham, Bianca C. Bernardo, Kevin Huynh, Jenny Y.Y. Ooi, Xiao Ming Gao, Helen Kiriazis, Corey Giles, Peter J. Meikle, Julie R. McMullen
Published 2018-09-01

Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.

by Bianca C Bernardo, Xiao-Ming Gao, Yow Keat Tham, Helen Kiriazis, Catherine E Winbanks, Jenny Y Y Ooi, Esther J H Boey, Susanna Obad, Sakari Kauppinen, Paul Gregorevic, Xiao-Jun Du, Ruby C Y Lin, Julie R McMullen
Published 2014-01-01